2346
M. Péter et al. / Tetrahedron: Asymmetry 9 (1998) 2339–2347
3.8. Gram-scale resolution of cis-2-(benzyloxycarbonylamino)-4-cyclohexene-1-methanol 7
Racemic cis-7 (0.8 g, 3 mmol) was dissolved in diethyl ether (76 ml), and vinyl butyrate (4 ml, 32
mmol) and lipase M (2 g) were added. The mixture was stirred at room temperature for 3 hours. The
enzyme was filtered off at 50% conversion. The work-up was the same as for 3.
20
D
The resulting butyrate enantiomer (1S,2R)-7b is a colourless oil (0.45 g, 1.36 mmol; [α] =−35
1
(c=0.25, CHCl3); 97% ee). H NMR (400 MHz, CDCl3) δ(ppm): 0.94 (t, 3H, J=7.3 Hz), 1.61–2.41
(m, 9H), 3.96–4.18 (m, 3H), 4.94 (d, 1H, J=8.7 Hz), 5.04–5.12 (ABq, 2H, J=18.2 Hz), 5.60–5.69 (m,
2H), 7.30–7.42 (m, 5H). MS: 332 (M+1). C19H25NO4 calc. 68.85% C, 7.61% H, 4.23% N; found 68.25%
C, 7.68% H, 4.60% N.
The corresponding alcohol counterpart (1R,2S)-7 is a white solid (0.28 g, 1.07 mmol; mp: 97–98°C;
20
1
[α] =−20 (c=0.2, CHCl3); 98% ee). H NMR (400 MHz, CDCl3) δ (ppm): 1.56–1.62 (m, 1H),
D
1.95–2.13 (m, 3H), 2.43–2.48 (m, 1H), 3.24–3.31 (m, 1H), 3.46–3.52 (m, 1H), 3.65–3.69 (m, 1H),
4.24–4.27 (m, 1H), 4.99 (d, 1H, J=7.9 Hz), 5.03–5.11 (ABq, 2H, J=14.6 Hz), 5.58–5.60 (m, 1H),
5.68–5.71 (m, 1H), 7.33–7.37 (m, 5H). MS: 262 (M+1). C15H19NO3 calc. 68.93% C, 7.33% H, 5.36%
N; found 68.68% C, 7.59% H, 5.69% N.
3.9. Gram-scale resolution of trans-2-(benzyloxycarbonylamino)-4-cyclohexene-1-methanol 9
Racemic trans-9 (0.8 g, 3 mmol) was dissolved in diisopropyl ether (76 ml), and vinyl butyrate (4 ml,
32 mmol) and PPL (2 g) were added. The mixture was stirred at room temperature for 30 minutes. The
enzyme was filtered off at 49% conversion.
The same work-up as described for 3 afforded the butyrate enantiomer (1S,2S)-9b as a white solid,
20
D
crystallized in a refrigerator (0.41 g, 1.24 mmol; mp: 30–32°C; [α] =+49 (c=0.2, CHCl3); 95% ee).
1H NMR (400 MHz, CDCl3) δ (ppm): 0.93 (t, 3H, J=7.4 Hz), 1.59–1.66 (m, 2H), 1.93–2.45 (m, 7H),
3.85–3.86 (m, 1H), 4.03–4.14 (m, 2H), 4.84 (d, 1H, J=7.4 Hz), 5.02–5.12 (ABq, 2H, J=13 Hz), 5.58–5.65
(m, 2H), 7.29–7.41 (m, 5H). MS: 332 (M+1). C19H25NO4 calc. 68.85% C, 7.61% H, 4.23% N; found
68.14% C, 7.09% H, 4.14% N.
The corresponding alcohol counterpart (1R,2R)-9 is a white solid (0.30 g, 1.15 mmol; mp: 113–114°C;
20
1
[α] =−14 (c=0.3, CHCl3); 92% ee). H NMR (400 MHz, CDCl3) δ (ppm): 1.52–1.57 (m, 1H),
D
1.91–2.10 (m, 2H), 2.39–2.44 (m, 2H), 3.27–3.31 (m, 1H), 3.39–3.45 (m, 1H), 3.76–3.81 (m, 2H), 4.74
(d, 1H, J=8.1 Hz), 5.09–5.16 (ABq, 2H, J=15.1 Hz), 5.54–5.58 (m, 1H), 5.69–5.73 (m, 1H), 7.31–7.37
(m, 5H). MS: 262 (M+1). C15H19NO3 calc. 68.93% C, 7.33% H, 5.36% N; found 69.49% C, 7.28% H,
5.19% N.
Acknowledgements
This work was supported by a COPERNICUS project (Contract No. ERBCIPA-CT94-0121). GB and
FF thank OTKA for their financial support. JVdE thanks the Fund for Scientific Research, Flanders
(F.W.O., Belgium) for a ‘Krediet aan Navorsers’ (No. 1.5.930.95) and the ‘Ministerie voor Wetenschaps-
beleid’ for financial support. We are indebted to Amano Enzyme Europe and Novo Nordisk for the
generous gift of the lipases and proteases. PM thanks the Soros Foundation for financial support.